Aristro Capital Markets Ltd.
You Are On :   Home  |  Equity  |   Company Profile  |  Board Meetings
 
Equity
Equity Analysis
Price
Volume
Analysis
News Analysis
Corporate Action
Other Market
Company Profile
Board Meetings
Pharmaids Pharmaceuticals Ltd.
 
BSE Code 524572
ISIN Demat INE117D01018
Book Value (Rs.) 18.09
NSE Code NA
Dividend Yield  % 0.00
Market Cap  (Rs. Mn) 2262.78
TTM PE (x) 0.00
TTM EPS (Rs.) -2.06
Face Value (Rs.) 10  
Source DateBoard Meeting DateDetails
20-May-2025 23-May-2025 Audited Results
07-Feb-2025 12-Feb-2025 Quarterly Results
07-Nov-2024 13-Nov-2024 Quarterly Results
20-Aug-2024 28-Aug-2024 A.G.M.
05-Aug-2024 13-Aug-2024 the Unaudited Financial Results (Standalone & Consolidated) for the quarter and three months ended 30th June 2024.
21-May-2024 28-May-2024 Audited Results
02-Feb-2024 12-Feb-2024 Quarterly Results
03-Jan-2024 06-Jan-2024 Increase in Authorised Capital & Employees Stock Option Plan & Preferential Issue of shares & Inter alia to consider the following: 1. To increase the Authorised Share Capital of the Company. 2. To alter the Object Clause of Memorandum of Association of the Company. 3. To consider and approve issuance of Equity Shares of the Company to non-promoters on preferential issue basis (Other than cash) to acquire majority stake in Adita Bio Sys Private Limited subject to approval of the shareholders in the ensuing General Meeting. 4. To consider and approve ?Pharmaids Pharmaceuticals Limited ? Employee Stock Option Scheme 2024? subject to approval of the shareholders in the ensuing General Meeting. 5. To consider and approve ?Pharmaids Pharmaceuticals Limited ? Employee Stock Purchase Scheme 2024? subject to approval of the shareholders in the ensuing General Meeting. 6. To consider and approve of offer of shares under the ?Pharmaids Pharmaceuticals Limited - Employee Stock Purchase Scheme 2024? to the Eligible Employees/ Whole-time Director(s) of the Company exceeding 1% of issued capital, subject to approval of the shareholders in the ensuing General Meeting. 7. To convene and decide the date, time and venue of 01st Extra Ordinary General Meeting (EGM) for the financial year 2023-24. 8. To approve the appointment of Scrutinizer for the said meeting, fix the cutoff date and evoting dates, agencies and all other matters connected with the EGM. 9. Any other matter with the permission of chair.
06-Nov-2023 11-Nov-2023 Quarterly Results
23-Aug-2023 29-Aug-2023 Inter alia, to consider and approve:- 1. To appoint a Scrutinizer to ascertain Voting Process of 34th Annual General Meeting of the Company, 2. To approve draft Notice of 34th Annual General Meeting (AGM) and to decide the date, time and venue of the AGM, To consider and fix Record date and/or Book closure date for the purpose of 34th Annual General Meeting.
close X

Download Client Registration Documents

Client Registration Documents in Vernacular Languages

Member: NSE CAPITAL MARKET: INB231498438 | NSE FUTURE & OPTION: INF231498438 | BSE CAPITAL MARKET: INB011498434 | BSE FUTURE MARKET: INF011498434 | DP REGN No.:IN-DP-CDSL-704-2013 | Single SEBI Registration nos.: NSE & BSE: INZ000219238 | DP CDSL: IN-DP-407-2019
Attention Investor: Update your mobile number and email id with your stock broker.
Home| About Us | Services | Login | Research | Online Trading | Customer Support | Useful links | SEBI SCORE | Contact Us | Investor Charter | Share Links:  
Terms & Conditions |Disclaimer | Privacy Policy |Policy & Procedure | Feedback | Open An Account | Downloads |Customer Desk |Policy |Site Map |Segregation and Monitoring of Collateral
NSE | BSE | SEBI | NSDL | NCDEX | CDSL | MCX | NMCE | MCX-SX | RBI | Do & Don'ts | CDSL Circular | CDSL e-Voting | Rights & Obligations | Risk Disclousre Document
Details of Authorised Persons | Basic Details | SMART ODR | Policy on Handling of Good Till Cancelled Orders
Copyright Aristro Capital Markets Ltd. All Rights Reserved.
Designed, Developed & Content Powered By  Accord Fintech Pvt. Ltd.